Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Osteopore Limited is an innovative medical technology company specializing in the development and commercialization of bioresorbable implants designed to facilitate natural bone healing. Central to its product lineup are advanced 3D-printed scaffolds, produced with proprietary micro-structured designs that support bone regeneration in various therapeutic areas, particularly craniofacial and neurosurgical procedures. The company’s solutions, such as Osteoplug and Osteomesh, are notable for mimicking natural bone structures to promote tissue repair, gradually dissolving as the bone heals to eliminate the need for secondary surgeries. Operating internationally, including in Singapore, Australia, and several Asian, European, and American markets, Osteopore Limited also engages in medical device sales, technology services, and research and development initiatives. Positioned within the healthcare sector and the medical instruments and supplies industry, Osteopore Limited contributes to the evolving landscape of regenerative medicine by providing cutting-edge, bioresorbable solutions that address complex clinical needs for bone restoration.